GregFolin

$AXXA Shares Keep Life Tough for Shorts

Long
OTC:AXXA   Exxe Group Inc.
Exxe Group Inc (OTCMKTS:AXXA) has responded extremely well since our last piece.

But the fundamental dynamic hasn't changed: the stock is carrying shorts higher on strong performance data and scalable operations, and the trend in place isn't hard to see.

We first covered Exxe Group Inc (OTCMKTS:AXXA) about a month ago, when the stock was trading at approximately $0.02 per share. Our case was simple:

Here is a stock with too many complacent shorts shorting too many shares, especially given that the financial prospects of the company appear legitimate. AXXA has strong exposure to high-growth themes, including fintech and cryptocurrency. And its execution shows no significant holes, which sets up the potential for strong Q numbers when they hit.

All of that would suggest the potential for a squeeze under normal circumstances. But these aren’t normal circumstances. We are now trading a market thoroughly deadly for bears and shorts. The tape is littered with bear skins. Look at GME, TLRY, BB, AMC… the list goes on. Half the OTC could be on that list by now.

The playing field is sloped right now due to free commissions, stimulus checks, a rising tide, a Fed set on driving inflation even at the expense of bubbles, and a very mature bull market at the height of its euphoria stage.

Thematically, AXXA has real revenue growth in the MM range being driven by its newly established Bitcoin services segment when Bitcoin is the toast of Wall Street.

Just about in every single respect imaginable, this stock is a ticking time bomb for exposed, entrenched shorts. We said so a month ago. We would say that is actually still the case now… and perhaps more than ever.

Has a 500% intense face-ripping squeeze rally taught anyone a lesson? Apparently not. In the past 5 days, according to OTCshortreport.com, well more than half of all transactions in AXXA have been shortside trades.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.